Ra 11223 - Universal Health Care Act (Uhc Law)
Ra 11223 - Universal Health Care Act (Uhc Law)
1. Leadership in health
2. Enabler and capacity builder
3. Administrator of specific services
PROFILE
To develop national plans, technical standards, and guidelines on health
To regulate all health services and products
To provide of special tertiary health care services and technical assistance to health providers and stakeholders
MISSION
To lead the country in the development of a productive, resilient, equitable and people-centered health system
VISION
Filipinos are among the healthiest people in Southeast Asia by 2022, and Asia by 2040
Provision to every Filipino of the highest possible quality of health care that is accessible, efficient, equitably distributed, adequately funded,
fairly financed, and appropriately used by an informed and empowered public.
1. Financial risk protection through expansion in enrollment and benefit delivery of the National Health Insurance Program (NHIP)
2. Improved access to quality hospitals and health care facilities
3. Attainment of health-related Millenium Development Goals
RA 5527 AO # 2005-0027
-Philippine Medical Technology Act of 1969 -Rules and regulation governing the accreditation of lab
-June 21, 1969 performing HIV testing
-August 15, 2005
RA 7719
-National Blood Services Act of 1994 AO # 2007-0027-A
-May 5, 1994 -Exempts regional and national TB reference lab from securing
license to operates as clinical lab
RA 4688 -August 22, 2007
-The Clinical Laboratory Law of 1996
-June 18, 1996 AO # 2008-0022
-Policies and Guidelines in the collaborative approach of TB and
RA 91656 HIV PREVENTION and Control
-Comprehensive Dangerous Drugs Act 2002 -August 8, 2008
-January 23, 2002
AO # 2010-0028
RA 9288 -Policies & Guidelines in the conduct of HIV counseling & health
-Newborn Screening of 2004 facility settings
-April 7, 2004 -September 27, 2010
RA 7170
-Organ Donation Act of 1991
-January 7, 1992
DENGUE
Mosquito-borne infection
Causes Dengue Hemorrhagic Fever and Dengue Shock Syndrome
No treatment but the disease can be early managed
o Female mosquito – humans
o Male mosquito – plants
o IV treatment – for rehydration
4 SEROTYPES / STRAINS
DENV1 – non-sever/asymptomatic
DENV2
DENV3
DENV4 - critical; leads to clotting of blood that causes death
NS1 Antigen - test required for symptoms ranging from 1-5 days.
NS1 Antigen, IgM, IgG - test required for symptoms ranging from 1-5 days.
TLR (Toll Like Receptor) – response and signal the presence of virus
SYMPTOMS
LAB TESTS
Dengue NS1
-Use to detect dengue virus antigen during early phase of acute dengue infection;
-Requested between 1-5 days of illness
Dengue IgM/IgG
-Used to detect dengue antibodies during acute late stage of dengue infection (IgM) and to determine previous infection (IgG)
-May give false positive result due to antibodies induced by dengue vaccine
-May cross react with other arboviral disease such as Chikungunya and Zika
Additional Notes:
PRIMARY
CBC
Urinalysis/ Fecalysis
SECONDARY
HEMA/CBC
FBS
CHEMISTRY
CHOLESTEROL
TERTIARY
PBS
HIV – CD4
– Normal
– Pneumonia